Skip to main content
Caplight Logo









Riboxx GmbH

Riboxx GmbH

Private
DresdenHealthcare & Life Scienceshttps://www.riboxx-pharma.com/en/

Last Round

Crowdfunding

Jan 31, 2015

Total Funding Raised

$2.69M

Company Overview

Riboxx GmbH is a biotechnology company that develops, manufactures, and markets unique active substances for the immunotherapy of cancer and viral diseases, as well as molecular tools for RNA interference research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Non-AI

Keywords

RNA immunotherapyTLR3 agonistbiotech drug discoveryRNA synthesisGMP manufacturingimmunology researchbiotech CDMOoncology therapeuticsRNA interferenceRNA therapeuticsdrug development servicesbiotech reagentsgene knockdownadjuvant development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Riboxx GmbH Comparables

Compare Riboxx GmbH with similar companies based on industry and business-model similarity.

Riboxx GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oncovir, Inc.
82%
Highlight Therapeutics
81%
RIGImmune Inc.
76%

Riboxx GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJan 31, 2015
GrantJan 1, 2011
SeedDec 1, 2009

Riboxx GmbH Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 31, 2015

    Raised $1.16M in a crowdfunding round.

  • Jan 1, 2011

    $1.53M grant from the German Federal Ministry of Education and Research.

Riboxx GmbH Filings

Explore SEC and related filing metadata, where available.

Riboxx GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Riboxx GmbH's valuation, stock price, and market status.

Is Riboxx GmbH a public or private company?

Riboxx GmbH is a private company.

What is the current stock price of Riboxx GmbH?

Riboxx GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Riboxx GmbH worth (valuation)?

Valuation information for Riboxx GmbH is not publicly available.

Can I buy Riboxx GmbH stock?

Riboxx GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Riboxx GmbH's last funding round?

Riboxx GmbH's most recent funding round was Crowdfunding on January 31, 2015.

Who are the main investors in Riboxx GmbH?

Key investors in Riboxx GmbH include Bundesministerium für Bildung und Forschung, SIB Innovations- und Beteiligungsgesellschaft, TUDAG.

Will Riboxx GmbH IPO soon?

No public IPO plans have been announced for Riboxx GmbH.

How can I track Riboxx GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Riboxx GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDresden
Year Founded2009
Last FundingJan 31, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?